multiple myeloma

Showing 1 - 25 of 1,882

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Cells From miRNAs Released From B Cells, and

Recruiting
  • Multiple Myeloma
    • Aviano, Pordenone, Italy
      Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
    Nov 23, 2023

    Multiple Myeloma Trial in Paris (Idecabtagene vicleucel, Not treated)

    Active, not recruiting
    • Multiple Myeloma
    • Idecabtagene vicleucel
    • Not treated
    • Paris, France
      DESCAR-T Registry
    Nov 27, 2023

    Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

    Not yet recruiting
    • Multiple Myeloma
    • (no location specified)
    Nov 28, 2023

    Determine the Optimal Initial Therapy for Multiple Myeloma

    Recruiting
    • Multiple Myeloma
    • Non-Interventional Study
    • Scottsdale, Arizona
    • +3 more
    Nov 22, 2023

    Clinical Pathways for Newly Diagnosed Multiple Myeloma

    Not yet recruiting
    • Multiple Myeloma
    • Multiple Myeloma Without Mention of Remission
    • Multiple Myeloma Pathway
    • +2 more
    • (no location specified)
    Nov 27, 2023

    Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

    Not yet recruiting
    • Multiple Myeloma
    • Supportive Care (home-based physical activity)
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 22, 2023

    Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,

    Not yet recruiting
    • Multiple Myeloma
    • Renal Failure
    • Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
    • Augusta, Georgia
      Georgia Cancer Center-Augusta University
    Nov 16, 2023

    Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,

    Recruiting
    • Multiple Myeloma
    • +2 more
    • Wuhan, Hubei, China
      Institute of Hematology, Union Hospital, Tongji Medical College,
    Nov 18, 2023

    Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

    Not yet recruiting
    • Refractory Multiple Myeloma
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Nov 17, 2023

    Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

    Recruiting
    • Multiple Myeloma
    • APRIL-BAFF-Bicephali CAR-T cells
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 14, 2023

    Identify Barriers to Cellular Therapies for People With Plasma

    Recruiting
    • Multiple Myeloma
    • Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
    • +5 more
    • Basking Ridge, New Jersey
    • +6 more
    Nov 6, 2023

    Multiple Myeloma Trial (CM313 injection)

    Not yet recruiting
    • Multiple Myeloma
    • CM313 injection
    • (no location specified)
    Nov 6, 2023

    Multiple Myeloma Trial in Boston (BMS-986393, Alnuctamab, Mezigdomide)

    Not yet recruiting
    • Multiple Myeloma
    • Boston, Massachusetts
    • +1 more
    Nov 2, 2023

    Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

    Not yet recruiting
    • Multiple Myeloma
    • +3 more
    • (no location specified)
    Oct 30, 2023

    MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With

    Not yet recruiting
    • Multiple Myeloma
    • Minimal Residual Disease
      • (no location specified)
      Nov 1, 2023

      Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma

      Not yet recruiting
      • Multiple Myeloma
      • Frailty
        • (no location specified)
        Oct 30, 2023

        Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the

        Not yet recruiting
        • Multiple Myeloma
        • +2 more
        • 18F-fluciclovine injection
        • 18F-FDG PET/CT
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 31, 2023

        Multiple Myeloma Trial in Houston (Belumosudil mesylate)

        Not yet recruiting
        • Multiple Myeloma
        • Belumosudil mesylate
        • Houston, Texas
          M D Anderson Cancer Center
        Oct 31, 2023

        Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

        Not yet recruiting
        • Multiple Myeloma
        • (no location specified)
        Oct 25, 2023

        Multiple Myeloma Trial (AZD0305)

        Not yet recruiting
        • Multiple Myeloma
        • (no location specified)
        Oct 24, 2023

        Multiple Myeloma Trial in Miami (Teclistamab, Talquetamab, Daratumumab SC)

        Not yet recruiting
        • Multiple Myeloma
        • Miami, Florida
          University of Miami
        Oct 20, 2023

        Multiple Myeloma Prognostic Indices

        Recruiting
        • Multiple Myeloma
        • Hematologic Diseases
        • blood viscosity , albumin / fibrinogen ratio and red cell distribution
        • Assiut, Egypt
          Assiut University hospital
        Oct 17, 2023

        Multiple Myeloma Trial in Wollongong (IBI3003)

        Not yet recruiting
        • Multiple Myeloma
        • Wollongong, New South Wales, Australia
          Wollongong Private Hospital
        Oct 18, 2023

        Multiple Myeloma Trial in Canton (Lenalidomide)

        Recruiting
        • Multiple Myeloma
        • Canton, Ohio
          Gabrail Cancer & Research Center
        Oct 11, 2023